Gentamicin is a valuable and widely used antibiotic, but in systemic therapy the range between therapeutic and potentially toxic serum levels is narrow (Reeves, 1974) . For this reason gentamicin assays are performed more frequently than for any other antibiotic (Reeves and Bywater, 1975) .
At present the common assay method is the plate diffusion bioassay which, although simple and inexpensive, is slow and, in many laboratories, inaccurate (Reeves and Bywater, 1975) . The shortcomings of the plate technique have prompted the development of alternative methods. The urease method (Noone et al., 1971 ) is founded on a simple principle, but its reliability remains in some doubt (Reeves, 1972; Phillips et al., 1974 ; Reeves and Bywater, 1975) . Radioenzymatic methods based on adenylylation (Smith et al., 1972; Phillips et al., 1974; ten Krooden and Darrell, 1974) or acetylation (Broughall and Reeves, 1975; Stevens et al., 1975) of gentamicin, and radioimmunoassays employing tritiated (Mahon et al., 1973; Berk et al., 1974; Stevens et al., 1975) or 1251-labelled (Broughton and Strong, 1976; Watson et al., 1976b) Received for publication 18 November 1976 require skilled manipulations in effecting a crucial separation step, involve a radiation hazard, and suffer from the high cost of the necessary radiochemicals, associated reagents, and capital equipment. A polarisation fluoroimmunoassay for gentamicin, based on detection of the extent of antibody binding of fluorescein-labelled gentamicin by measurement of fluorescence polarisation, has been developed (Watson et al., 1976a) . Compared with radioimmunoassay, this method benefits from nonradioactive, easily prepared, and stable labelled material, and from the absence of a separation step, which simplifies and speeds the assay procedure. However, an obstacle to the widespread use of this technique is that a sialisedpolarisation fluorimeter is required if measurements are to be made sufficiently rapidly and conveniently for most routine purposes.
We now report a new fluoroimmunoassay method for gentamicin which exploits the observation that the fluorescence of fluorescein-labelled gentamicin is partially quenched upon binding by anti-gentamicin serum. When an appropriate amount of antiserum is added to a mixture of unlabelled (for example, from a serum sample) and labelled gentamicin, competition for antibody binding occurs and the extent of fluorescence quenching in the unseparated immunoassay incubation mixture, estimated by conventional fluorimetry, may be 526 related to the gentamicin content of the sample by means of a suitably prepared standard curve. The method is termed 'quenching fluoroimmunoassay'.
Material and methods

REAGENTS
The preparation of fluoresceinthiocarbamyl gentamicin (FTC-gentamicin) by the reaction of gentamicin with fluorescein isothiocyanate followed by column chromatographic purification on Sephadex G-15 is described in detail elsewhere (Watson et al., 1976a) . A stock solution, stored at 4°C, in 0 05 M sodium carbonate-bicarbonate buffer, pH 9 0, with a content of immunoreactive gentamicin of 3-3 mg/I, as assessed by radioimmunoassay (Watson et al., 1976b) , was used.
Anti-gentamicin serum was raised in rabbits by immunisation with conjugates produced by coupling gentamicin to bovine serum albumin by the carbodiimide method (Watson et al., 1976b) . Primary immunisation was carried out by injection at multiple intradermal sites of01 mgof theimmunogen in 1 ml of an emulsion of equal parts by volume of water and Freund's complete adjuvant. Six weeks later, a booster injection was administered in the same way. Bleeds were taken two weeks after the booster injection and the sera were characterised for FTC-gentamicin binding capacity by means of antibody dilution curves based on fluorescence quenching or fluorescence polarisation (Watson et al., 1976a) Aliquots (0 5 ml) of the diluted samples or standards were pipetted in duplicate into two series of tubes. To each tube of one series was then added 0-5 ml of a 1:200 dilution in buffer of the stock FTC-gentamicin solution. After vortex mixing, 0-5 ml of a 1:80 dilution in buffer of anti-gentamicin serum was added to each tube and the contents were immediately vortex mixed again. To each tube of the other series was added 1 ml of buffer and the contents were vortex mixed. This latter series served for estimation of the fluorescence blank signals contributed by the intrinsic fluorescence of the serum samples or standards themselves.
The assay mixtures and blanks were incubated at room temperature for any convenient period longer than 5 minutes (typically 15 minutes to 2 hours) to ensure immunochemical equilibration. After incubation, the fluorescence signals of the assay mixtures and blanks were measured in the fluorimeter. The corresponding blank signal was subtracted from the total signal of each assay mixture. (The intrinsic fluorescence of the antiserum makes a constant small contribution to the total signal of each assay mixture and therefore need not be corrected.) The method was as described elsewhere (Watson et al., 1976a) 
PRECISION
The gentamicin reference solution was added to pooled normal human serum (a different batch from that used for preparation of assay standards) so as to provide for samples with the equivalent of 2 5, 50, and 10-0 mg/l serum gentamicin content.
Within-assay precision was assessed by measuring each sample 20 times, giving coefficients of variation of 3 0, 5 3, and 6 5%, respectively, at these concentrations. For estimation of between-assay precision, aliquots of the samples were stored frozen until required. Each sample was measured in 20 independent assays, giving mean results of 2 55, 5 15, and 1017 mg/I gentamicin with coefficients of variation of 4 9, 4-9, and 11 00, respectively. the equation y = 1 00.x -0-2 (units: mg/l serum gentamicin), and the correlation coefficient (r) takes the value 0-98. The bioassay was sensitive to 1-25 mg/l serum gentamicin, and five trough samples reported as below this limit gave consistent results by quenching fluoroimmunoassay. The correlation between bioassay and quenching fluoroimmunoassay of the remaining 44 samples is shown in Figure 4 . The least squares regression of bioassay results (y) on quenching fluoroimmunoassay results (x) is given byy = 1-07x + 0-6,r = 0-84.
Fluorescence blank signals from serum samples were found to vary from about 3% of the total signal of assay mixtures for normal sera to as much as 15 %, notably with visually turbid patient samples (and presumably attributable in such cases to light scattering rather than genuine fluorescence).
In 24 of the assayed patient samples, creatinine levels above the upper normal limit of 120 ,umol/l (1-4 mg/100 ml) indicated impaired renal function, and 16 of these showed levels in excess of 500 ttmol/l (5-7 mg/100 ml), the highest being 1110 ,umol/l (12-6 mg/100 ml). However, serum blank signals were found to be unrelated to creatinine level, and no difficulty was encountered in the quenching fluoroimmunoassay of these samples.
Although the present results were obtained using a spectrophotofluorimeter equipped with monochromators and a xenon arc lamp source, it 
Discussion
The results presented show that, given due attention to precision in pipetting and fluorimetry, the quenching fluoroimmunoassay method described gives reliable estimations of serum gentamicin levels.
Comparison with published data indicates that precision and accuracy are better than those of most bioassays (Reeves and Bywater, 1975) , at least as good as adenylylating radioenzymatic assays (Smith cet al., 1972; Phillips et al., 1974; ten Krooden and Darrell, 1974; Broughall and Reeves, 1975) and similar to acetylating radioenzymatic assays (Broughall and Reeves, 1975; Stevens et al., 1975) , radioimmunoassays (Mahon et al., 1973; Berk et al., 1974; Stevens et al., 1975; Broughton and Strong, 1976; Watson et al., 1976b) , and polarisation fluoroimmunoassay (Watson et al., 1976a) . At all three gentamicin levels tested, assay accuracy falls within statistical limits classed by Reeves and Bywater (1975) as 'good' and of real value in monitoring and controlling gentamicin therapy.
Good correlation is found between assay of patient serum samples by the quenching fluoroimmunoassay and the polarisation fluoroimmunoassay method which has been previously shown (Watson et al., 1976a) Thirdly, serum samples display intrinsic light absorbance which will attenuate the intensities of the exciting and (usually to a lesser extent) emitted light beams within the fluorimeter cell. This is the so called inner filter effect (Udenfriend, 1969) . Any difference between the intrinsic absorbance of a serum sample and that of the pooled normal serum used for preparation of assay standards will give rise to spurious quenching or enhancement of the fluorescence of FTC-gentamicin when measured in an assay mixture containing the serum sample, relative to that measured in a standard assay mixture containing the pooled normal serum. It is essential for the accuracy of the method that such effects be small compared with other sources of error. The results of recovery experiments, and the good correlation with the polarisation fluoroimmunoassay method (which is not subject to inner filter effect interference) show this to be the case in practice, even for patient sera from cases of severe renal impairment. Since all patient samples examined were shown to differ in optical density (1 cm antibody dilution curve to find the optimum antiserum dilution. Finally, the initial dilution of serum samples should be fixed so as to obtain the desired sensitivity.
The mechanism of the fluorescence quenching observed when FTC-gentamicin is bound by antigentamicin serum is not known. The results of immunisation of several animals show, however, that there is every reason to be optimistic that the quenching effect is a property of at least the majority of anti-gentamicin sera.
The quenching fluoroimmunoassay of gentamicin is more rapid and technically simpler than any method of comparable reliability. The required serum sample size is small enough to cope with most eventualities. Because FTC-gentamicin has practically indefinite shelf life and may be easily and economically prepared in large quantity (contrast, for example, 1251-labelled gentamicin), the cost of the labelled material can be essentially negligible. The only significant recurrent cost of routine assays might be that involved in raising or possibly purchasing anti-gentamicin serum. The only capital equipment required is a conventional fluorimeter. 
